MyFinsight
Home
Blog
About
Back
Income Statement
Beam Therapeutics Inc. (BEAM)
Beam Therapeutics Inc. (BEAM)
source: myfinsight.com
Comprehensive gain
-$123,797K
(-20.85%↓ Y/Y)
Interest and other income
(expense), net
$7,487K
(-39.26%↓ Y/Y)
Gain on sale of equity
method investment
$455K
Change in fair value of
non-controlling equity...
$338K
(-92.34%↓ Y/Y)
Net gain
-$122,678K
(-19.93%↓ Y/Y)
Unrealized gain (loss) on
marketable securities
-$1,119K
(-646.00%↓ Y/Y)
Total other income
(expense)
$3,875K
(-78.30%↓ Y/Y)
Change in fair value of
derivative liabilities
-$4,200K
(-466.17%↓ Y/Y)
Change in fair value of
contingent consideration...
$205K
(632.14%↑ Y/Y)
Loss from operations
-$126,553K
(-5.33%↓ Y/Y)
License and
collaboration revenue
$490K
(-94.21%↓ Y/Y)
Total operating
expenses
$127,043K
(-1.22%↓ Y/Y)
Research and development
$95,096K
(-6.55%↓ Y/Y)
General and
administrative
$31,947K
(18.94%↑ Y/Y)
Back